Green Brick Partners, Inc.
GRBKAbout the company
Green Brick Partners, Inc., the third largest homebuilder in Dallas-Fort Worth, is a diversified homebuilding and land development company that operates in Texas, Georgia, and Florida. Green Brick owns five subsidiary homebuilders in Texas (CB JENI Homes, Normandy Homes, Southgate Homes, Trophy Signature Homes, and a 90% interest in Centre Living Homes), as well as a 50% interest in a homebuilder in Atlanta, Georgia (The Providence Group) and an 80% interest in a homebuilder in Port St. Lucie, Florida (GHO Homes).
Investment snapshot
Positive
11
BUY / PASS
Neutral / negative
3 / 2
NEUTRAL / FAIL
Median fair value
$85.76
+40.4% vs price
Models with upside
8 / 17
Positive margin of safety
Strongest signal
Split decision: 8 PASS · 3 BUY · 3 NEUTRAL · 2 FAIL
Key risk
All 8 investors flag GRBK's efficiency
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | PASS | PASS | FAIL | Not ranked | PASS | PASS | BUY | NEUTRAL | PASS | NEUTRAL | PASS | BUY | PASS | BUY | PASS | NEUTRAL | FAIL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||
| Margin of Safety | +26.2% | +28.8% | +65.4% | +25.3% | N/A | +43.6% | +46.9% | +49.0% | +69.1% | -11.2% | -10.9% | -4.2% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-09-30 · Annual history · FY 2025 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-25 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-25 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-25 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-25 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-25 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-25 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-28 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-10-28 Score computed: 2026-11-14 |
Where It Passes
- Verdicts85% pass✓ 11✗ 2▾
Split decision: 8 PASS · 3 BUY · 3 NEUTRAL · 2 FAIL
Overall verdict✓GrahamPASS (4/9)✓BuffettPASS (4/9)✗LynchFAIL (4/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 4)✓DremanPASS (5/11)✓MungerBUY (3/4)•PabraiNEUTRAL (2/3)✓AkrePASS (3/6)•MarksNEUTRAL (4/5)✓AckmanPASS (5/9)✓TempletonBUY (7/8)✓SleepPASS (3/6)✓AsnessBUY (Rank #228/2370 (Top 9.6%))✓NeffPASS (5/6)•SchlossNEUTRAL (4/7)✗OshaughnessyFAIL (Rank #463/963 (Top 48.1%)) - Valuation models73% pass✓ 8✗ 3▾
Models split on GRBK at $61.07 — fair values range $54.91–$197.43
Graham fair value$82.73✓Graham+26.2% margin vs $61.07Buffett fair value$85.76✓Buffett+28.8% margin vs $61.07Lynch fair value$176.75✓Lynch+65.4% margin vs $61.07Greenblatt fair value$81.75✓Greenblatt+25.3% margin vs $61.07Dreman fair value$108.30✓Dreman+43.6% margin vs $61.07Munger fair value$115.08✓Munger+46.9% margin vs $61.07Pabrai fair value$119.68✓Pabrai+49.0% margin vs $61.07Akre fair value$197.43✓Akre+69.1% margin vs $61.07Marks fair value$54.91✗Marks-11.2% margin vs $61.07Ackman fair value$55.05✗Ackman-10.9% margin vs $61.07Templeton fair value$58.63✗Templeton-4.2% margin vs $61.07 - Debt & Leverage67% pass✓ 11✗ 4▾
8 of 12 pass — Graham, Lynch, Dreman +1 more object
LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.17, IC: No interest expense✓BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.09✓Lynch< 0.33Cash - Long-term Debt$-168.7M✗LynchPositive preferredLT Debt / Total Assets Change15.11% -> 12.75%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.09✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.09✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=N/A (no interest expense), D/EBITDA=0.7x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.09✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.0928; #1244/4210 (top 29.5%)✓AsnessTop 30% of eligible cross-section - Valuation62% pass✓ 19✗ 9▾
8 of 13 pass — Greenblatt, Dreman, Asness +2 more object
Price / Book Value per Share1.4x✗Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Price / 3-yr avg EPS8.5x✓Graham<= 15xPrice-to-Book Ratio1.4x✓Graham<= 1.5xP/E x P/B12.00✓Graham<= 22.5Basic earnings-growth PEG (dividends excluded)0.33✓Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value15.9%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=15.9%, ROC=None✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS8.6x✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)12.4x✗Dreman< 8xValuation ReasonablenessP/E=8.6x, OE Yield=11.9%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=8.6x, FCF Yield=8.0%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=8.6x, P/B=1.4x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value43.6% (IV=$108.30 vs Price=$61.07)✓Marks>= 20% below intrinsic valuePrice / FCF per Share12.7x✓Ackman<= 25Price vs. Trailing Low105% of trailing low ($58.31)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization+10.52%; #596/6340 (top 9.4%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.7788; #1987/6449 (top 30.8%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS8.6x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E3.00✓Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share1.46x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+239.1%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.7564; #2109/5247 (top 40.2%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+2.70%; #2108/4519 (top 46.6%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-9.20%; #3390/6202 (top 54.7%)✗OshaughnessyTop 10% of eligible cross-section
Where It Falls Short
- Efficiency0% pass✗ 11▾
All 8 investors flag GRBK's efficiency
Current Ratio✗Graham>= 2.0ROIC (3-5 yr avg)9.4%✗Buffett> 10%ROIC - WACC-0.6%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)✗Greenblatt> 25%Current Ratio Change YoY✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.92x -> 0.80x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities✗Dreman> 1.5Return on Invested Capital✗Munger> 15%ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)✗SleepROIC > 12% in a majority of years - Cash Flow30% pass✓ 5✗ 7▾
7 of 10 flag GRBK's cash flow — Lynch, Piotroski, Dreman +4 more
Free Cash Flow Proxy$313.5M✓BuffettPositive and growingFCF Positive and Growing$69.9M✗LynchPositive and growingOperating Cash Flow$213.2M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=8.41%, ROA=12.36%✗PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)12.4x✗Dreman< 8xP/E or FCF YieldP/E=8.6x, FCF Yield=8.0%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive8/16 years FCF positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap2.7%✗Ackman>= 4%Price / FCF per Share12.7x✓Ackman<= 25Positive Operating Cash Flow frequency8/16 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$69.9M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+2.70%; #2108/4519 (top 46.6%)✗OshaughnessyTop 10% of eligible cross-section - Profitability38% pass✓ 19✗ 16▾
10 of 16 flag GRBK's profitability — Graham, Buffett, Lynch +7 more
Positive EPS (10 years)14/20 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)14/20 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)22.3%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)11.5% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$313.5M✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)0.33✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR25.8%✓Lynch15-30% (Fast Grower); > 0% to passROE13.5%✗Lynch> 15%EBIT / Enterprise Value15.9%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=15.9%, ROC=None✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets12.36%✓PiotroskiROA > 0ROA Change YoY16.96% -> 12.36% (delta: -4.60%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=8.41%, ROA=12.36%✗PiotroskiCFO/Assets > ROAGross Margin Change YoY34.1% -> 31.4%✗PiotroskiImproved YoYPre-Tax Income / Revenue19.1%✓Dreman>= 8%Net Income / Shareholders' Equity13.5%✓Dreman> 12%Margin of SafetyP/E=8.6x, P/B=1.4x✓PabraiP/B < 1.5 or P/E < 15Return on Equity20.7% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic Value43.6% (IV=$108.30 vs Price=$61.07)✓Marks>= 20% below intrinsic valuePositive Net Income Frequency14/16 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue✗Ackman>= 15%Net Income / Shareholders Equity13.5%✗Ackman>= 15%5-Year EPS CAGR25.8% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization+10.52%; #596/6340 (top 9.4%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+20.99%; #2002/3702 (top 54.1%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+13.51%; #1324/5226 (top 25.3%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0202; #1447/5884 (top 24.6%)✓AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR25.8% over 5 years✗Neff7%-20% annualizedPositive Diluted-EPS Years10/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Growth38% pass✓ 7✗ 6▾
5 of 8 flag GRBK's growth — Graham, Dreman, Ackman +2 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)0.33✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR25.8%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthN/A (no inventory)✓LynchInventory growth < Revenue growthEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency14/16 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-0.5%✗Ackman>= 5%Positive EPS Growth Frequency4/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR25.8% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR15.9%✓SleepCAGR > 7%3-5 Year Diluted EPS CAGR25.8% over 5 years✗Neff7%-20% annualized
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 2.9% of shares last year, 4.0% over two.
- Buybacks
- $83.8M
- Dividends
- $2.9M
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, gross profit, pre tax income, operating cash flow, depreciation amortization, capex, dividends paid, buybacks. | Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex, dividends paid. | Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex, dividends paid, buybacks. | Q1 · 2026-03-31 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.6Bcurrent | -- | -- | -- | $3.0Best. | $2.7Best. | $2.3Best. | $1.4Best. | $1.2Best. |
| Revenue | $2.0B↓7% | $448.2M↓10% | $493.8M↓10% | $465.5M↓6% | $2.0B↓1% | $2.1B↑18% | $1.7B | $1.8B↑25% | $1.4B |
| Operating Income | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | $272.6M↓19% | $59.2M↓24% | $74.2M↓9% | $60.9M↓19% | $313.2M↓18% | $381.6M↑34% | $284.6M↓2% | $291.9M↑53% | $190.2M |
| EPS (Diluted) | -- | $1.35↓24% | $1.70↓8% | $1.39↓17% | $7.07↓16% | $8.45↑38% | $6.14↑2% | $6.02↑62% | $3.72 |
| Gross Margin | 28.7%↓10% | 27.3%↓12% | 29.4%↓4% | 28.3%↓10% | 31.4%↓8% | 34.1%↑9% | 31.3%↑5% | 29.8%↑15% | 25.8% |
| Operating Margin | — | — | — | — | — | — | — | — | — |
| ROE | 13.5%↓28% | — | — | — | 16.8%↓28% | 23.5%↑7% | 21.9%↓20% | 27.5%↑26% | 21.7% |
| Total Debt | $187.2M↓29% | $187.2M↓29% | $237.2M↓14% | $237.1M↓14% | $323.3M↓5% | $339.9M↓3% | $350.5M↓6% | $371.9M↑10% | $339.5M |
| Shareholders' Equity | $2.0B↑12% | $2.0B↑12% | $2.0B↑14% | $1.9B↑13% | $1.9B↑14% | $1.6B↑25% | $1.3B↑22% | $1.1B↑21% | $874.5M |
| Current Ratio | — | — | — | — | — | — | — | — | — |
| Debt / Equity | 0.09↓36% | 0.09↓36% | 0.12↓24% | 0.12↓24% | 0.17↓17% | 0.21↓22% | 0.27↓23% | 0.35↓10% | 0.39 |
| Operating Cash Flow | $74.9M↓54% | -$52.5M↓415% | -$8.8M↓112% | $56.3M↓18% | $213.2M↑723% | $25.9M↓88% | $213.3M↑135% | $90.7M↑198% | -$92.4M |
| Free Cash Flow | $69.9M↓56% | -$53.7M↓347% | -$9.8M↓113% | $55.0M↓19% | $208.4M↑867% | $21.5M↓90% | $205.5M↑132% | $88.7M↑194% | -$94.4M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Construction
GRBK vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HITACHI LTDHTHIY | $137.0B | $30.83 | — | — | — | — | — | — | 1/9 | 0/9 | 2/7 | 0/3 | F-Score 7 | 3/11 |
| QUANTA SERVICES, INC.PWR | $90.7B | $602.01 | $28.5B | $1.0B | 11.5% | 0.67 | 5.7% | 1.14 | 1/9 | 1/9 | 3/7 | 1/3 | F-Score 5 | 3/11 |
| HORTON D R INC /DE/DHI | $39.5B | $145.55 | $34.3B | $3.6B | 14.8% | 0.25 | — | — | 4/9 | 2/9 | 4/7 | 0/3 | F-Score 4 | 4/11 |
| EMCOR Group, Inc.EME | $28.9B | $659.36 | $17.0B | $1.3B | 34.6% | 0.00 | 10.1% | 1.22 | 3/9 | 6/9 | 6/7 | 1/3 | F-Score 7 | 6/11 |
| PULTEGROUP INC/MI/PHM | $23.4B | $127.01 | $17.3B | $2.2B | 17.1% | — | — | — | 3/9 | 2/9 | 5/7 | 1/3 | F-Score 3 | 5/11 |
| JACOBS SOLUTIONS INC.J | $18.7B | $158.23 | $12.0B | $289.3M | 7.9% | 0.61 | 7.2% | 1.30 | 3/9 | 1/9 | 2/7 | 1/3 | F-Score 7 | 1/11 |
| MASTEC INCMTZ | $14.7B | $182.78 | $14.3B | $399.0M | 12.2% | 0.72 | — | 1.32 | 1/9 | 1/9 | 2/7 | 1/3 | F-Score 8 | 3/11 |
| Toll Brothers, Inc.TOL | $13.6B | $147.85 | $11.0B | $1.3B | 16.3% | 0.11 | 15.7% | — | 3/9 | 4/9 | 5/7 | 1/3 | F-Score 4 | 7/11 |